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Background. NOGO Receptor 1 (RTN4R) regulates axonal growth, as well as axon regeneration after injury. The gene maps to the
22q11.2 schizophrenia susceptibility locus and is thus a strong functional and positional candidate gene. Methodology/Principal
Findings. We evaluate evidence for genetic association between common RTN4R polymorphisms and schizophrenia in a large
family sample of Afrikaner origin and screen the exonic sequence of RTN4R for rare variants in an independent sample from the
U.S. We also employ animal model studies to assay a panel of schizophrenia-related behavioral tasks in an Rtn4r-deficient mouse
model. We found weak sex-specific evidence for association between common RTN4R polymorphisms and schizophrenia in the
Afrikaner patients. In the U.S. sample, we identified two novel non-conservative RTN4R coding variants in two patients with
schizophrenia that were absent in 600 control chromosomes. In our complementary mouse model studies, we identified
a haploinsufficient effect of Rtn4r on locomotor activity, but normal performance in schizophrenia-related behavioral tasks. We
also provide evidence that Rtn4r deficiency can modulate the long-term behavioral effects of transient postnatal N-methyl-D-
aspartate (NMDA) receptor hypofunction. Conclusions. Our results do not support a major role of RTN4R in susceptibility to
schizophrenia or the cognitive and behavioral deficits observed in individuals with 22q11 microdeletions. However, they suggest
that RTN4R may modulate the genetic risk or clinical expression of schizophrenia in a subset of patients and identify additional
studies that will be necessary to clarify the role of RTN4R in psychiatric phenotypes. In addition, our results raise interesting issues
about evaluating the significance of rare genetic variants in disease and their role in causation.
Citation: Hsu R, Woodroffe A, Lai W-S, Cook MN, Mukai J, et al (2007) Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using
Human and Mouse Genetic Approaches. PLoS ONE 2(11): e1234. doi:10.1371/journal.pone.0001234
INTRODUCTION
Axonal growth and regeneration is restricted during the
maturation of the central nervous system (CNS) as well as after
injury, and several lines of evidence indicate that myelin-associated
proteins play a critical role in these processes. Early seminal studies
by David and Aguayo, 1981 [Ref. 1] demonstrated that the CNS
environment contains inhibitory factors which limit growth, and
a number of myelin-associated growth inhibitory factors have since
been identified, including oligodendrocyte-myelin glycoprotein
(OMgp), myelin-associated glycoprotein (MAG), Nogo-A (RTN4),
and most recently, Ephrin-B3. Notably, despite their distinct
molecular structures, OMgp, MAG, and RTN4 all share
a common receptor, Nogo Receptor 1 (RTN4R) [2–4]. RTN4R,
a glycosylphosphatidylinositol-linked (GPI-linked) cell surface mol-
ecule, forms a heteromeric receptor complex with either LINGO-1
and p75, or LINGO-1 and TROY (a tumor necrosis factor (TNF)
receptor family member). Activation of RTN4R initiates a cascade
that leads to the activation of RhoA and, ultimately, the inhibition of
axonal growth [5–7]. Given that it acts as a convergence point for
three separate factors, which inhibit neurite outgrowth and
regeneration, RTN4R has generated much interest as a target for
therapeutic intervention following CNS injury [2–4,8].
The human RTN4R gene is located within the 22q11.2 locus
where relatively common hemizygous microdeletions occur at
a frequency of 1 in 5000 live births [9]. The majority of these
deletions are de novo events and occur on different haplotype
backgrounds [10]. The physical phenotype of the 22q11.2 deletion
is broad and variable and most frequently includes congenital
heart defects, velopharyngeal defects, and thymic hypoplasia. In
addition, most patients display a pattern of cognitive impairments
and behavioral deficits, including deficits in working memory,
conflict monitoring, visuospatial short-term memory, and execu-
tive visual attention [11–14].
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PLoS ONE | www.plosone.org 1 November 2007 | Issue 11 | e1234In addition, a range of neuroanatomical abnormalities such as
reduced total brain volume, enlarged ventricles, and white matter
abnormalities [15,16] has been described in some 22q11.2
microdeletion carriers. Both syndromic and non-syndromic
patients with the deletion also show extremely high frequencies
of psychiatric illness, especially schizophrenia: children with the
deletion are 25–30 times more likely to develop schizophrenia or
schizoaffective disorder by early adulthood [17,18], and 22q11.2
microdeletions account for ,2% of schizophrenia cases in
Caucasian populations [19]. Children with this microdeletion
are also reported to have impaired sensorimotor gating [20],
which is considered an endophenotype of several psychiatric
disorders including schizophrenia, as well as a high incidence of
emotional problems including anxiety, depression, social with-
drawal, and obsessive-compulsive behaviors [13].
The possibility that RTN4R deficiency contributes to the
psychiatric symptoms associated with the 22q11.2 microdeletion,
in particular, is intriguing and supported by some preliminary
human genetic and gene expression studies. Although, collectively,
the human genetic and animal model studies designed to identify
schizophrenia susceptibility genes from the 22q11.2 region have
implicated primarily three genes: proline dehydrogenase
(PRODH), ZDHHC8 and catechol-O-methyltransferase (COMT)
[21–25] and their interactions [26,27], a study by Liu et al. [22]
presented suggestive evidence that common variants located at the
39 end of the RTN4R gene are associated with schizophrenia in
patient samples from the U.S. and South Africa. There has been
one attempt to replicate these initial findings in the Han Chinese
population, with negative results [28]. However, two preliminary
reports described sex-specific associations between schizophrenia
and common variants in the RTN4R gene [29], as well as its ligand
RTN4 [30]. In addition, Sinibaldi et al. [31] reported two rare
non-conservative sequence variants in the RTN4R gene in an
Italian sample of 120 schizophrenia patients that were absent in
a sample of 200 controls. Moreover, alterations in the levels of
RTN4R or two RTN4R ligands have been described in
postmortem analyses of brains from individuals with schizophre-
nia. Specifically, microarray expression studies and single-gene
quantitative RT-PCR studies indicate a down-regulation of MAG
in at least some schizophrenia cohorts [32,33] and one preliminary
study suggested that levels of RTN4 mRNA are also increased in
the cortex of some individuals with chronic schizophrenia [34].
Finally, a recent meta-analysis of several expression profiling
studies revealed a ,10% decrease (P=0.019) of RTN4R transcript
levels in brains of individuals with schizophrenia (www.stanleyge-
nomics.org). It is unclear, however, whether the observed changes
constitute part of the genetic diathesis in schizophrenia or
represent a reactive response. Here, we undertake a comprehensive
multi-pronged approach to explore the possibility that RTN4R is
a schizophrenia susceptibility gene from the 22q11.2 locus.
RESULTS
Search for rare RTN4R coding variants
The RTN4R protein is encoded by two exons: exon I, which codes
for the first 7 amino acids, and exon II, which encodes amino acids
8–473 (Fig. 1A). We sequenced exon II of RTN4R in 208
individuals with schizophrenia from the U.S. (European ancestry)
and identified five variants. Of these five variants, three were
synonymous changes (L18L, S192S, P394P), and two resulted in
non-conservative changes (T134M, L347R) in evolutionary
conserved amino acids (Fig. 1B, C). Each of these five variants
was identified in single individuals except for S192S, which was
found in two individuals. We also sequenced exon II of RTN4R in
a sample of 300 control individuals from the U.S. and found only
two synonymous changes (L18L, S192S). The S192S variant was
identified in a single individual, whereas the L18L variant was
found in two individuals. Previously, Sinibaldi et al. [31] reported
two non-conservative sequence variants in the RTN4R gene
(R119W and R196H) in an Italian sample of 120 schizophrenia
patients that were absent in 200 controls. In our sample, we did
not find these two variants in our patient sample, but we did find
the synonymous L18L variant reported in the same study.
The RTN4R protein is comprised of two domains: an
extracellular N-terminal ectodomain containing eight leucine-rich
repeats (LRRs) and a membrane-anchored C-terminal domain
containing a glycosylphosphatidylinositol (GPI) anchor sequence
[35]. The ectodomain is both necessary and sufficient for binding
the RTN4 ligand [35] and the C-terminal domain containing the
GPI sequence and the connecting ‘‘stalk’’ is required for
interaction with at least one of the co-factors, p75 [36]. The
T134M variant we identified in one female patient is located in the
concave face of the ligand-binding ectodomain of RTN4R, within
the fourth LRR. Based on the crystal structure of the soluble
ectodomain [37,38] the T134 residue is found on the concave face
within a negatively charged patch of amino acids including D111,
D114, C138, D139, which forms a slight local depression which
could be important for ligand or partner interactions [38]
(Fig. 1D). The other non-synonymous variant we identified in
one male patient, L347R, is positioned within the ‘‘stalk’’ of
RTN4R that is required for p75 interaction.
Association analysis
Given the difficulties in assessing the significance of association to
rare variants, primarily due to a lack of power [39], we sought to
obtain additional supportive data by testing for independent
association with common variants of RTN4R (Fig. 1A) in families
with schizophrenia. Previously, we provided weak evidence for an
association between RTN4R variation and susceptibility to
schizophrenia by identifying three distinct variants located at the
39 end of the RTN4R gene that were preferentially transmitted in
individuals with schizophrenia in two independent, family-based
samples from the U.S. (N=106 triads) and South Africa (N=93
triads) [22]. Here, we expand the South African sample to 312
families by including an additional 219 families with at least one
schizophrenic subject (see Table S1 for study population char-
acteristics). Since it has been suggested that variants in RTN4R may
affectschizophreniasusceptibilitydifferentlyinmalesandfemaleswe
conducted both combined and sex-stratified analyses.
To facilitate comparison, three of the five single nucleotide
polymorphisms (SNPs) tested in the present study (rs665780,
rs701427, and rs696880) were also included in the earlier study
[22]. Two of these SNPs previously showed weak evidence for
association in that study: rs665780 in the Afrikaner families only
(P=0.04) and rs701427 in the U.S. families only (P=0.02). Four
of the five SNPs in this study are within the RTN4R intron and one
is located 39 of the gene. All SNPs are common with a minor allele
frequency of at least 20% (see Table 1 for SNP positions and
minor allele frequencies). The average (6SD) R
2 and D’ between
the ten pairs of SNPs are 0.33 (60.42) and 0.62 (60.48),
respectively. In the HapMap subjects of European descent (CEU),
these five SNPs tag the common (minor allele frequency .10%)
SNPs in RTN4R with an average R2 (6SD) of 0.75 (60.39). Three
of the five SNPs (rs701427, rs854971, and rs696880) are separated
by less than 2-kb and are in high linkage disequilibrium (LD) with
each other (R
2$0.90), (see Table 2 for pair-wise values). This
group of SNPs, however, shows relatively low LD with the two
flanking SNPs (rs665780 and rs1567871).
RTN4R and Schizophrenia
PLoS ONE | www.plosone.org 2 November 2007 | Issue 11 | e1234Transmission disequilibrium test (TDT) analysis did not find
evidence for unequal allelic transmission ratios at any of the tested
variants in the combined sample (data not shown). Application of
the more powerful linkage and association modeling in pedigrees
(LAMP) analysis (Table 3) on the combined sample also provided
no evidence for unequal allelic transmission. In a sex-stratified
analysis, SNP rs696880 showed the most significant association in
females (Sch1: RRA=0.74, P=.064; Sch2: RRA=0.73, P=.046)
Figure 1. Genetic variation at the RTN4R locus. (A) Location of human RTN4R within chromosomal region 22q11.2. Exons are represented by blue
bars. The rs numbers of the SNPs typed in the present study are shown. SNPs genotyped by Liu et al. [22] are indicated by arrowheads (those SNPs
that showed significant association with schizophrenia are shown in red arrowheads). The association observed with the three SNPs at the 39end of
RTN4R was independent from the association observed more proximally in the vicinity of the ZDHHC8 gene [22]. (B) Complete amino acid sequence
of RTN4R. Rare coding variants identified in the U.S. schizophrenia sample are shown in blue (synonymous) or red (missense). Two missense variants
reported by Sinibaldi et al. [31] are shaded in grey. (C) Evolutionary conservation across species of the missense variants identified in this study at
amino acid positions 134 (top) and 347 (bottom). (D) Surface (left) and cartoon (right) representation of the crystal structure of the ligand-binding
ectodomain of RTN4R. The variant at residue 134, drawn in red, is shown as the wild-type threonine (top) and the mutated methionine (bottom).
Prepared using Pymol (DeLano Scientific, LLC, San Francisco, CA).
doi:10.1371/journal.pone.0001234.g001
Table 1. Position and minor allele frequency of SNPs
......................................................................
SNP
Position
(in Mb)
Position
(in Gene)
Major/Minor
Alleles
Minor Allele
Frequency
rs665780 18.560 39 T/C .21
rs701427 18.608 intronic C/A .34
rs854971 18.608 intronic G/A .34
rs696880 18.610 intronic A/G .36
rs1567871 18.616 intronic C/T .24
doi:10.1371/journal.pone.0001234.t001
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Table 2. Pair-wise LD values
......................................................................
rs665780 rs701427 rs854971 rs696880 rs1567871
rs665780 - ,.01 ,.01 ,.01 ,.01
rs701427 .05 - .99 .90 .16
rs854971 .05 1.00 - .91 .16
rs696880 .06 .99 1.00 - .17
rs1567871 .08 .99 .99 .98 -
doi:10.1371/journal.pone.0001234.t002
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PLoS ONE | www.plosone.org 3 November 2007 | Issue 11 | e1234and non-significant trends were also obtained with the other two
linked SNPs, rs701427 and rs854971. In affected males, suggestive
evidence for association was observed at rs701427 (Sch1:
RRC=1.19, P=.10; Sch2: RRC=1.21, P=.019), as well as at
the two SNPs (rs696880 and rs854971) in high LD with it.
Interestingly, the alleles of rs701427, rs854971, and rs696880 that
appear to increase susceptibility to schizophrenia in males show
a trend towards decreasing the risk in females, consistent with the
observed lack of association in the combined sample. A Bonferroni
correction for multiple SNPs and affection statuses results in a P-
value threshold of 0.0042. Therefore, after correcting for multiple
testing, none of these results are significant.
When we estimate the haplotype frequencies in our population
using an Expectation Maximization (E-M) algorithm, we observe six
common haplotypes (frequency $5%) and one additional haplotype
with a frequency $1%. The TDT analysis reveals a proportionate
transmission of all haplotypes (data not shown). Similarly,the LAMP
analysis does not detect any association between a haplotype and
schizophrenia either in the combined or in the sex-stratified sample
(see Table 4 for the results from the LAMP analyses).
Generation of Rtn4r-deficient mice
In order to complement our human genetic studies (see
Discussion), we generated a mouse model that is deficient in the
Rtn4r gene and probed for deficits in phenotypic components,
which include endophenotypes associated with schizophrenia that
can be modeled reliably in mice [40].
The mouse ortholog of RTN4R is located in the syntenic region
of the human 22q11.2 locus that lies on mouse chromosome 16.
All human genes except for one are represented in this region,
although the order of the genes is different [41]. As a result of this
rearrangement, the Rtn4r mouse gene is located between the Prodh
gene (,40-kb proximal) and the Zdhhc8 gene (,70-kb distal)
(Fig. 2A), both of which have been implicated by human genetic
studies as strong candidate susceptibility genes for schizophrenia
[21–23]. To minimize the possibility that genetic modification of
the Rtn4r locus could affect expression of the two neighboring
genes, we designed and implemented a gene targeting strategy
(Fig. 2B–F) to replace exon II of Rtn4r with the self-excisable
selection cassette that includes the neo gene selectable marker
(pACN) [40]. Excision of the neo gene, following germline
transmission, ensures that any observed phenotype is due to the
deletion rather than any long-range transcriptional effects of the
selection cassette [42]. Homozygous Rtn4r mutant mice were
viable and fertile and have normal brain morphology by gross
morphological inspection, as well as finer morphometric calcula-
tions of cell densities, laminal thickness and the thickness of the
corpus callosum (see Text S1 and Fig. S1).
Behavioral characterization of Rtn4r-deficient mice
at baseline
We characterized wild-type, heterozygous, and homozygous Rtn4r
mutant mice at baseline using tasks designed to assess domains
known to be perturbed in schizophrenia, including anxiety,
sensorimotor gating, learning and memory, and behavioral despair.
Rtn4r-deficient mice demonstrated normal neurological signs and
normal pain threshold levels using the hot plate assay (data not
shown). In addition to locomotor activity and anxiety-related tasks,
we assessed a)sensorimotorgating using the prepulse inhibition (PPI)
assay; b) cognitive performance using contextual and cued fear
conditioning, as well as a working memory task; and c) a depression-
relevantbehavior using the tail-suspensionassay.Fora description of
the equipment and procedures used, see Text S2.
Open field and anxiety-relevant tasks In the open field
assay there was a significant effect of genotype on the total distance
traveled in the open field [F(2, 60)=4.192, P,0.02] and number
Table 3. LAMP results for individual SNPs
......................................................................
SNP Allele Sch1 Sch2
RR P-Val RR P-Val
All rs665780 T 1.12 - 1.10 -
rs701427 C 0.97 - 0.98 -
rs854971 G 0.97 - 0.98 -
rs696880 A 0.96 - 0.96 -
rs1567871 C 0.98 - 1.01 -
Females rs665780 T 1.23 - 1.23 -
rs701427 C 0.73 .062 0.74 .054
rs854971 G 0.74 .070 0.74 .064
rs696880 A 0.74 .064 0.73 .046
rs1567871 C 1.12 - 1.18 -
Males rs665780 T 1.02 - 1.00 -
rs701427 C 1.19 - 1.21 .019
rs854971 G 1.18 - 1.20 .021
rs696880 A 1.17 - 1.18 .029
rs1567871 C 0.91 - 0.91 -
*RR=risk ratio; P-Val=P-value of TLD statistic.
*Bonferroni corrected P-value cutoff=.0050.
doi:10.1371/journal.pone.0001234.t003
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Table 4. LAMP results for haplotype analysis (frequency..05)
......................................................................
Haplotype* Freq Sch1 Sch2
RR P-Val RR P-Val
All TCGAC .34 0.94 - 0.94 -
TAAGC .27 1.05 - 1.01 -
TCGAT .17 1.10 - 1.10 -
CAAGC .07 0.97 - 1.06 -
CCGAC .07 0.95 - 0.98 -
CCGAT .06 0.89 - 0.82 -
Females TCGAC .34 0.93 - 0.92 -
TAAGC .27 1.28 .053 1.29 .055
TCGAT .17 0.89 - 0.87 -
CAAGC .07 1.30 - 1.27 -
CCGAC .07 0.46 .054 0.59 -
CCGAT .06 0.86 - 0.77 -
Males TCGAC .34 0.96 - 0.98 -
TAAGC .27 0.90 - 0.84 -
TCGAT .17 1.20 .058 1.23 .061
CAAGC .07 0.78 - 0.90 -
CCGAC .07 1.32 .083 1.28 .081
CCGAT .06 0.94 - 0.91 -
*Alleles for rs665780, rs701427, rs854971, rs696880, and rs1567871, respectively.
*Rare haplotypes (not included in analysis: TCGGC (.018); CCGGC (.007); TCGGT
(.001); TAGAC (.001); TAAGT (,.001).
*RR=risk ratio; P-Val=P-value of TLD statistic.
*At a-level of .05, Bonferroni corrected P-value is .0042.
doi:10.1371/journal.pone.0001234.t004
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PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1234of rears (vertical movements) [F(2, 60)=9.14, P,0.001] (Fig. 3A,
B). Interestingly, reductions in distance traveled and rears were
observed in both the homozygous mutant and heterozygous mice
in comparison to wild-type littermates suggesting that the gene
could be haploinsufficient with respect to these behaviors. There
were no differences in habituation of locomotor activity in the
open field (not shown). Differences in the percentage of distance
traveled in the central area of the open field, an index of anxiety-
relevant behavior, fell short of significance [F(2, 60)=2.11,
P=0.071] (Fig. 3C). In the light/dark test, which also assays for
anxiety-relevant behaviors, we found no genotype or genotype X
sex effects on the number of entries into each compartment
(Fig. 3D) or on the percentage of time animals spent in the light
compartment of the light/dark apparatus (data not shown).
Sensorimotor Gating Sensorimotor gating is typically
evaluated using the PPI paradigm, a common measure of pre-
attentive processing [40]. Abnormal PPI has been described in
individuals with schizophrenia, as well as in children with the
22q11.2 microdeletion syndrome [20]. In this model, the response
to a startle-eliciting stimulus, such as a loud tone, is attenuated if
the stimulus is preceded within a few hundred milliseconds by
a lower-intensity stimulus, or pre-pulse [43,44]. We evaluated
startle response to auditory stimuli as well as inhibition of the
startle response elicited by pre-pulses. There were no genotype or
genotype X sex differences in inhibition of the startle response at
any of the prepulse levels of 70, 80 and 85 dB (Fig. 3E). In
addition, in control experiments, there were no genotype or
genotype X sex effects on acoustic startle response (120 dB)
(Fig. 3F). Notably, although there was no significant effect of
genotype, homozygous mutants tended to show slightly more
inhibition of startle response than wild-type littermate control
mice, as well as slightly less startle response.
Associative learning and memory We used the Pavlovian
conditioned fear paradigm to assess associative learning and
Figure 2. Targeting the Rtn4r locus for homologous recombination. (A) Gene map of the Rtn4r locus at mouse chromosome 16. (B) Exon II of Rtn4r
was replaced by the self-excisable pACN cassette including the neo gene for selection. Genomic DNA was digested with XbaI and the 39 probe was
used for southern blot analysis. A PCR strategy was designed to genotype offspring using primer sets A1/A2 and B1/B2. (C) Genomic southern blot of
ES cell DNA and tail biopsies. Wild-type fragments were 14.6-kb, recombinant fragments from ES cells were 7.4-kb, and recombinant fragments from
tail biopsies after pACN cassette excision were 3.8-kb. (D) PCR genotyping of tail biopsies using primer sets A1/A2 and B1/B2. Wild-type mice yielded
2.2-kb and 0.5-kb fragments from sets A1/A2 and B1/B2 respectively; homozygotes yielded 0.7-kb and no fragment, respectively; and heterozygotes
yielded 0.7-kb and 0.5-kb fragments, respectively. (E) Northern blot of total brain RNA using a Rtn4r 39UTR probe. (F) RT-PCR of total brain RNA using
isoform-specific primers for Rtn4r exon II.
doi:10.1371/journal.pone.0001234.g002
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PLoS ONE | www.plosone.org 5 November 2007 | Issue 11 | e1234Figure 3. Behavioral characterization of Rtn4r-deficient mice. (A) Total distance traveled, (B) mean number of rears, and (C) ratio of center traveled
distance/margin traveled distance in a 20-min open field test. (D) Number of dark-to-light transitions in a 10-min dark/light transition test. (E) PPI
using combinations of one startle level (120 dB) and three prepulse levels (70, 80 and 85 dB). (F) Startle response at 120 dB. (G) Contextual and cued
fear-conditioning paradigm. Activity (beam breaks) was measured at baseline, after reintroduction into the same context where training occurred
(context), at baseline in an altered context (altered), and after presentation of the cued conditioned stimulus in the altered environment (cue). (H)
Accuracy in a working memory test after a 5-sec or 20-sec inter-trial delay using a delayed alternation T-maze assay. (I) Mean time spent immobile in
a tail suspension test. All results shown are from combined sexes. All data are represented as mean6S.E.M.
doi:10.1371/journal.pone.0001234.g003
RTN4R and Schizophrenia
PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1234memory in Rtn4r-deficient mice (Fig. 3G). We evaluated both
contextual conditioning, as measured by suppressed activity in the
context where training occurred, and cued conditioning as
measured by suppression of activity in a new environment in
which the conditioned stimulus (CS) is presented.
Baseline activity
There were no genotype differences or genotype X sex effects in
baseline activity during the training phase of fear conditioning.
There were also no differences in activity levels after the third
presentation of the unconditioned stimulus (US) and tone pairing.
Contextual Conditioning
There were no genotype or genotype X sex effects in activity
during contextual conditioning.
Altered Context
There were no genotypic differences in activity levels in the altered
context test, which is both amygdala- and hippocampus-de-
pendent [F(2, 60)=2.11, P=0.13]; however, there was a significant
genotype X sex interaction in activity levels in the altered
environment [F(2, 60)=4.2, P,0.02].
Cued Conditioning
In the cued version of the test, which requires the amygdala but
not the hippocampus [45], there were no genotype or genotype X
sex effects in the suppression of activity in response to the
conditioned stimulus.
Working memory We used the T-maze delayed alternation
task [46,47] to examine whether deficiency in Rtn4r-mediated
signaling activity is associated with changes in spatial working
memory. Working memory is defined as the ability to maintain
and manipulate information transiently in the service of other
cognitive processes to guide behavior [48]. Working memory is
frequently impaired in patients with schizophrenia (often prior to
or at the onset of the illness), as well as in a portion of their non-
schizophrenic, first-degree relatives [49,50]. Impaired working
memory has also been noted in individuals with the 22q11.2
microdeletion syndrome [12–14]. Rtn4r-deficient mice learned the
5-sec delay T-maze task during 6 consecutive training days and
performed as well as wild-type littermate control mice. In addition,
there were no genotypic differences or genotype X sex interactions
in their T-maze based working memory performance at both 5-sec
and 20-sec delays (Fig. 3H).
Behavioral despair High rates of depressive symptoms have
been observed in patients with schizophrenia [51] and children
with the 22q11.2 microdeletion [12]. We assayed for behavioral
despair, an index of depression-like behavior in rodents, using a tail
suspension test [52]. The test is based on the fact that animals
subjected to the short-term, inescapable stress of being suspended
by their tail will develop an immobile posture. Various
antidepressant medications reverse the immobility and promote
the occurrence of escape-related behavior [53]. No genotypic
differences or genotype X sex interactions in total time spent
immobile on the tail suspension task were observed (Fig. 3I). A
repeated measures ANOVA also showed that there were no
genotypic differences or genotype X sex interactions in time spent
immobile over intervals of the test session.
Behavioral characterization of Rtn4r-deficient mice
following transient postnatal NMDAR blockade
Recent work using an independent animal model suggests that
RTN4R may function in the mammalian CNS to stabilize neural
circuits in early postnatal development [54]. It is therefore
conceivable that RTN4R deficiency facilitates the effect of other
schizophrenia susceptibility genes or disease-related pathological
processes by destabilizing relevant neural circuits during de-
velopment. Such a contribution might not be detectable with the
study design outlined above but may require additional genetic or
pharmacological challenges. Aberrant NMDA receptor-mediated
glutamatergic transmission has been implicated in psychiatric
disorders such as schizophrenia, and several pharmacological
modeling approaches have been established based on this
hypothesis [40]. In one of them, transient inhibition of NMDAR
signaling during early postnatal development produces long-lasting
behavioral deficits including deficits in domains such as cognitive
flexibility, working memory and sensorimotor gating [55,56]. We
employed this model to ask whether Rtn4r deficiency modulates
the long-term behavioral effects of postnatal NMDA receptor
hypofunction. In our experimental paradigm, mouse pups were
given injections of the NMDA channel blocker MK-801 during
two distinct periods: postnatal days (P) 7–10, which corresponds to
a critical period of sensitivity for the NMDAR system, and P11–
14, which follows the critical period [57,58]. Sensorimotor gating,
as well as spontaneous alternation (an index of normal working
memory) and motoric activity in the Y-maze were then tested in
adulthood.
Spontaneous alternation Adult homozygous Rtn4r-deficient
mice and their wild-type littermates showed, as expected,
a tendency to spontaneously alternate but there were no
significant differences in spontaneous alternation in the Y-maze
due to genotype or drug treatment (Fig. 4A). However, we observed
a significant genotype X treatment interaction (P,0.05) in the
percentage of time moving, a measure of locomotor activity.
Specifically, a significant genotype effect was observed in animals
that were injected with MK-801 but not saline at P7–10 (P,0.05).
Interestingly, this effect was limited to animals treated at P7–10.
Animals that underwent the same treatment at P11–14 showed no
significant genotype X treatment interaction (Fig. 4B). Further
analysis showed that this difference emerged because while neonatal
MK-801 treatment at P7–P10 induced an increase in locomotor
activityinthewild-typemiceinadulthood,itresultedinadecreasein
locomotor activity of adult Rtn4r-deficient mice (Fig. 4C).
Acoustic startle and prepulse inhibition There were no
overall significant differences in prepulse inhibition or acoustic
startle response due to genotype or drug treatment (Fig. 4D, E).
Previously, Harris et al. [56] found that neonatal MK-801
administration resulted in a greater decrease in PPI levels in
adult females only. However, we found no significant sex effect in
both acoustic startle response and prepulse inhibition.
DISCUSSION
Several lines of evidence suggest that oligodendroglial function and
myelin maintenance are disturbed in schizophrenia [reviewed in
Davis et al. [59]]. These include imaging and neurocytochemical
evidence, changes in white matter, myelin-related gene abnor-
malities, and morphologic abnormalities in the oligodendroglia
observed in brains of individuals with schizophrenia. The relation
of these findings to the pathogenesis of the disease is still uncertain.
Most intriguing is the possibility of a relation between deficits in
myelination and function of the prefrontal cortex, a region that
modulates many functions impaired in schizophrenia and whose
myelination is completed during late adolescence and early
adulthood, a period when overt symptomatology of schizophrenia
most commonly emerges. In this context, the location of RTN4R
within the replicated and highly penetrant 22q11.2 schizophrenia
susceptibility locus makes the gene a prime candidate for
influencing disease susceptibility.
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in a large sample of Afrikaner families. Given that Afrikaners are
a relatively genetically and environmentally homogenous popula-
tion, we expected higher power in our analysis, making disease
susceptibility alleles easier to identify. Our analyses did not identify
SNPs or haplotypes that were segregating with the disease in the
overall sample. Stratification by sex provided weak evidence for an
association between RTN4R and schizophrenia, which did not
survive a conservative Bonferroni correction.
We also identified rare non-synonymous changes within the
RTN4R gene of schizophrenia patients but not in unaffected
controls. This observation appears to lend some support for a role
of RTN4R in disease susceptibility. However, the major limitation
in conducting association analyses of rare variants is that it is
Figure 4. Behavioral characterization of adult Rtn4r-deficient mice following transient postnatal NMDAR blockade. (A, B) Percentage of
alternation (A) and % time moving (B) observed in an 8-min session of a Y-maze spontaneous alternation assay, repeated over 2 days. Animals were
injected with MK-801 or saline for 4 consecutive days during either P7–10 or P11–14; behavioral testing was conducted at P62 and P63. (C) Relative
effect of MK-801 injection normalized to saline injection on time spent moving. (D) Average percentage of PPI (measured at P91) in animals injected
during either P7–10 or P11–14. (E) Mean startle response to a 40 ms, 120 dB acoustic stimulus in animals injected during either P7–10 or P11–14.
Startle response was measured at P91.
doi:10.1371/journal.pone.0001234.g004
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interpret their results. In our study, the sample of several hundred
chromosomes does not have sufficient power for our results to be
considered unequivocal in proving the association between rare
variants of RTN4R and schizophrenia [39,60,61]. Therefore, we
cannot exclude the possibility that all four RTN4R non-
conservative variants that have been described in patients with
schizophrenia (present study and in Sinibaldi et al. [31] study)
might actually be rare variants that are neutral in relation to the
disease status. In general, interpreting association tests between
rare variants and complex traits is an emerging problem in the
field [62,63]. The significance of rare variants such as the ones
identified in this study can be addressed by screening thousands of
both patient and control chromosomes for the presence of non-
synonymous variants [61], by searching for rare non-synonymous
variants in extended pedigrees (i.e. ones that show linkage to the
22q11.2 locus) where co-inheritance of rare non-conservative
variants with disease status can be strictly evaluated, as well as by
using model systems to strengthen a functional link between
variation in the gene and the disease.
In the context of suggestive human genetic data, the generation
of genetic mouse models that mimic the effect of rare
hypomorphic variants can be particularly informative [40]. Our
animal model studies, designed to facilitate interpretation of our
human genetic results, indicated an effect of Rtn4r on locomotor
activity in an open field assay. Furthermore, in heterozygous Rtn4r
mice, we found a haploinsufficient effect in the open field assay.
However, in schizophrenia-related behavioral tasks, such as PPI
and the working memory-dependent T-maze delayed alternation
task, our studies revealed an unremarkable behavioral profile with
normal performance in these tasks, thus arguing against a major
role of RTN4R in susceptibility to schizophrenia. It should be
noted that using an independently generated Rtn4r-deficient
mouse model, Kim et al. [64] also observed hypoactivity in Rtn4r
null mice along with decreased rotarod performance, but normal
Basso-Beattie-Bresnahan (BBB) scores, a measure of locomotor
function. Schizophrenia-related behavioral tasks were not reported
in the Kim et al. [64] study.
Obviously, positive results from accurate genetic mouse models
can be instrumental in establishing the ‘‘biological plausibility’’ of
disease-associated genetic variants. However, any interpretation
based on negative results from behavioral studies in animal models
suffers from several caveats that reflect the limitations of
behavioral approaches and the complex genetic structure of the
disease. For example, the behavioral effect of any given mutation,
especially in a gene that could be involved in a complex disorder,
could depend on the age and genetic background of the organism.
In addition, we cannot ignore the possibility that RTN4R
deficiency contributes to other phenotypic components not
assayed here. In that respect, future studies designed to examine
the effect of Rtn4r deficit in younger animals or in inbred genetic
backgrounds including additional hypothesis-driven behavioral
assays will be informative.
Behavioral assessment at baseline may also overlook modulatory
effects of a gene in a given behavior that may be revealed by
additional genetic or pharmacological challenges. NMDA hypo-
function is considered one of the leading hypotheses for
schizophrenia pathogenesis and has inspired the generation of
several pharmacological models of the disease. Indeed, by
adapting such a pharmacological model we found that neonatal
NMDAR disruption during a presumably critical period for
NMDA activity (P7–10), differentially affects wild-type and Rtn4r-
deficient mice. During critical periods of development, widespread
pharmacological or genetic inhibition of NMDAR signaling has
been shown to facilitate terminal axon sprouting and to modulate
the effects of activity-based competition on axon growth
[58,65,66]. Such ‘‘wiring’’ alteration may contribute not only to
the behavioral deficits associated with this pharmacological model,
but also to the disease pathogenesis. Moreover, Rtn4r may modulate
this aspect of NMDA hypofunction on early brain wiring.
Interestingly, and in agreement with our behavioral analysis at
baseline, the observed effects were specific to the motor domain.
Although it is very difficult to extrapolate from motor deficits in
mice to deficits in motor skills in humans, it is worth noting that
patients with schizophrenia display motor development delays, as
well as motor disturbances [67,68]. It is also worth noting that
motor deficits have been consistently observed in children with the
22q11.2 deletion syndrome including an impairment in fine and
gross motor skills that emerges during adolescence [11,69,70].
Importantly, a recent study has shown that motoric deficits are
more prevalent among 22q11.2-deleted individuals with schizo-
phrenia than without schizophrenia and along with deficits in
verbal learning and social cognition can be used to distinguish
these two groups of patients [71].
Our results do not support a major role of RTN4R in
susceptibility to schizophrenia or in the cognitive and behavioral
deficits observed in individuals with 22q11 microdeletions.
However, a hypothesis emerging from the findings described
here, as well as from previous independent work (see Introduction)
is that RTN4R may modulate the genetic risk for psychiatric
phenotypes in a subset of patients, at least partly by mediating the
developmental effects of NMDAR receptor hypofunction on early
brain wiring. Further genetic studies in afflicted families, as well as
analysis of the knockout mice in additional behavioral, synaptic
and molecular phenotypes are warranted and will be necessary to
test this hypothesis and further clarify any role of RTN4R in
psychiatric phenotypes.
MATERIALS AND METHODS
Sample description
All procedures of subject recruitment and evaluation were
approved by the Institutional Review Boards at Rockefeller
University, New York State Psychiatric Institute and University
of Pretoria. Written informed consent was obtained from all
participants. The sample used for direct sequencing consisted of
208 individuals with schizophrenia, of European ancestry,
recruited from the U.S. and diagnosed by a clinical team specially
trained in the use of the Diagnostic Instrument for Genetic Studies
(DIGS) [72] and the research application of the Diagnostic and
Statistical Manual–4th Edition (DSM-IV) [73]. On the basis of the
information gathered in the DIGS, the clinical interviewers
assigned appropriate diagnoses according to the DSM-IV. The
control sample used for direct sequencing consisted of 60 parents
from CEPH trios (residents of Utah with ancestry from Northern
and Western Europe) and an additional set of 240 healthy
Caucasians collected from the U.S. by us (MK). Sequencing
analysis was performed as described in Text S2.
To evaluate association between the RTN4R gene and
susceptibility to schizophrenia, we recruited participants from
312 Afrikaner families with at least one schizophrenic subject.
Afrikaners are descendants of mostly Dutch immigrants who
settled in South Africa beginning in 1652 [74]. Participants were
diagnosed in person by specially trained clinicians again using the
DIGS, which had been translated and back-translated into
Afrikaans. Patients were classified into two diagnostic categories.
The stricter category, Sch1, includes 348 individuals who meet
DSM-IV criteria for schizophrenia or depressed-type schizoaffec-
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alternative expressions of the same genotypes [75] and in the past
we have considered them together under one phenotypic liability
class, LC I [76]. The broader category, Sch2, includes an
additional 52 individuals diagnosed with schizoaffective disorder of
mainly affective course. Association analysis was performed as
described in Text S2.
Generation of Rtn4r knockout mice
For the construction of the targeting construct, we replaced an
Rtn4r genomic fragment encompassing exon II with the self-
excisable pACN cassette including the neo gene selectable marker
[77]. Cell culture, embryonic stem (ES) cell electroporation and
generation of the chimeric mice were performed essentially as
previously described [78]. Approximately 5% of the tested ES cell
clones were positive for homologous recombination, and one clone
was selected for injection into C57BL/6J blastocysts. Chimeric
males were mated with C57BL/6J females, and DNA from tail
biopsy samples from F1 agouti-coat pups was genotyped by
Southern blotting at the Rtn4r genomic locus (wild-type fragment:
14.6-kb; recombinant fragment after pACN cassette excision: 3.8-
kb). We mated F1 heterozygous mice and obtained F2 mice of all
three genotypes. The mutation was on a hybrid C57BL/66129Sv
background. All animal procedures were performed according to
protocols approved by the appropriate Institutional Animal Care
and Use Committee under the federal and state regulations.
Histological analysis
See Text S2.
Behavioral Testing: Equipment and Procedures
See Text S2.
Analysis following transient postnatal NMDAR
blockade
See Text S2.
SUPPORTING INFORMATION
Text S1
Found at: doi:10.1371/journal.pone.0001234.s001 (0.02 MB
DOC)
Text S2
Found at: doi:10.1371/journal.pone.0001234.s002 (0.06 MB
DOC)
Table S1
Found at: doi:10.1371/journal.pone.0001234.s003 (0.03 MB
DOC)
Figure S1 Brain histology in Rtn4r-deficient mice: Representa-
tive microphotographs from Nissl staining of coronal sections
through the cerebral cortex (A, B), anterior-dorsal hippocampus
(C, D) and corpus callosum (E, F) from 8-wk-old Rtn4r-deficient
mice (2/2) and their wild-type littermates (+/+). (G, H) Coronal
sections through the cerebral cortex of Rtn4r recombinant mice
crossed with Thy1-YFPH expressing transgenics. Scale bars
represent 0.4 mm. (I) Average cell density of the retrosplenial
agranular cortex at Bregma 22.18 mm, 21.70 mm, and
21.22 mm. (J) Average thickness of the retrosplenial agranular
cortex. (K) Average thickness of the corpus callosum. All data are
represented as mean6S.E.M.
Found at: doi:10.1371/journal.pone.0001234.s004 (9.10 MB TIF)
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